GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GNI Group Ltd (TSE:2160) » Definitions » Cyclically Adjusted PS Ratio

GNI Group (TSE:2160) Cyclically Adjusted PS Ratio : 10.65 (As of May. 23, 2024)


View and export this data going back to 2007. Start your Free Trial

What is GNI Group Cyclically Adjusted PS Ratio?

As of today (2024-05-23), GNI Group's current share price is 円2162.00. GNI Group's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was 円203.08. GNI Group's Cyclically Adjusted PS Ratio for today is 10.65.

The historical rank and industry rank for GNI Group's Cyclically Adjusted PS Ratio or its related term are showing as below:

TSE:2160' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 7.08   Med: 25.42   Max: 81.59
Current: 11.56

During the past years, GNI Group's highest Cyclically Adjusted PS Ratio was 81.59. The lowest was 7.08. And the median was 25.42.

TSE:2160's Cyclically Adjusted PS Ratio is ranked worse than
71.94% of 506 companies
in the Biotechnology industry
Industry Median: 5.665 vs TSE:2160: 11.56

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

GNI Group's adjusted revenue per share data for the three months ended in Mar. 2024 was 円114.521. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is 円203.08 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


GNI Group Cyclically Adjusted PS Ratio Historical Data

The historical data trend for GNI Group's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GNI Group Cyclically Adjusted PS Ratio Chart

GNI Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 55.15 26.74 15.71 10.37 14.81

GNI Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.24 8.48 11.34 14.81 15.22

Competitive Comparison of GNI Group's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, GNI Group's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GNI Group's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GNI Group's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where GNI Group's Cyclically Adjusted PS Ratio falls into.



GNI Group Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

GNI Group's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=2162.00/203.08
=10.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GNI Group's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, GNI Group's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=114.521/107.2000*107.2000
=114.521

Current CPI (Mar. 2024) = 107.2000.

GNI Group Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 2.709 98.000 2.963
201409 3.777 98.500 4.111
201412 5.888 97.900 6.447
201503 6.717 97.900 7.355
201506 7.346 98.400 8.003
201509 6.968 98.500 7.583
201512 8.093 98.100 8.844
201603 9.086 97.900 9.949
201606 6.872 98.100 7.509
201609 8.395 98.000 9.183
201612 13.926 98.400 15.171
201703 10.231 98.100 11.180
201706 10.160 98.500 11.057
201709 18.704 98.800 20.294
201712 29.313 99.400 31.613
201803 25.036 99.200 27.055
201806 27.905 99.200 30.155
201809 35.990 99.900 38.620
201812 33.715 99.700 36.251
201903 37.540 99.700 40.364
201906 44.084 99.800 47.353
201909 43.550 100.100 46.639
201912 46.829 100.500 49.951
202003 47.567 100.300 50.839
202006 50.653 99.900 54.354
202009 57.114 99.900 61.287
202012 62.491 99.300 67.463
202103 81.676 99.900 87.644
202106 53.986 99.500 58.164
202109 63.675 100.100 68.191
202112 64.789 100.100 69.384
202203 82.441 101.100 87.415
202206 88.596 101.800 93.296
202209 95.477 103.100 99.274
202212 97.020 104.100 99.909
202303 88.260 104.400 90.627
202306 207.607 105.200 211.554
202309 131.832 106.200 133.073
202312 105.788 106.800 106.184
202403 114.521 107.200 114.521

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


GNI Group  (TSE:2160) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


GNI Group Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of GNI Group's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


GNI Group (TSE:2160) Business Description

Industry
Traded in Other Exchanges
Address
Shinjuku Park Tower, 3-7-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, JPN, 163-1030
GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.

GNI Group (TSE:2160) Headlines

No Headlines